HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
QRICH1
glutamine rich 1
Chromosome 3 Β· 3p21.31
NCBI Gene: 54870Ensembl: ENSG00000198218.13HGNC: HGNC:24713UniProt: A1L3Z9
61PubMed Papers
21Diseases
0Drugs
73Pathogenic Variants
FUNCTIONAL ROLE
Highly ConstrainedTranscription Factor
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
DNA bindingprotein bindingendoplasmic reticulum unfolded protein responseresponse to endoplasmic reticulum stressVerveri-Brady syndrome 1Intellectual disabilitygenetic disordersyndromic complex neurodevelopmental disorder
✦AI Summary

QRICH1 (glutamine-rich protein 1) is a transcriptional regulator that coordinates cellular stress responses through multiple mechanisms. As a key effector of the integrated stress response, QRICH1 mediates ER stress outcomes by controlling transcription of proteostasis genes, translational networks, and secretory pathways 1. ER stress induces QRICH1 translation via eIF2Ξ± phosphorylation, allowing it to regulate a transcriptional program associated with protein translation, secretion-mediated proteotoxicity, and terminal UPR-associated cell death, potentially cooperating with ATF4 signaling 1. QRICH1 regulates ATF6 transcription to suppress pathological cardiac hypertrophy 2. Beyond ER stress, QRICH1 functions as a core component of the zincore complexβ€”a heterotetramer that stabilizes zinc finger transcription factors (ZFP91, ZNF652, ZNF526, PRDM15) onto cognate DNA motifs, controlling genome-wide gene expression 3. QRICH1 also negatively regulates CARD11 signaling to fine-tune CD8+ T cell activation and effector function 4. In bone development, QRICH1 regulates chondrocyte hypertrophy required for longitudinal growth 5. Heterozygous QRICH1 variants cause Ververi-Brady syndrome characterized by developmental delay, intellectual disability, facial dysmorphism, hypotonia, seizures, and structural brain anomalies 6, with emerging associations in polymicrogyria 7.

Sources cited
1
QRICH1 is a key effector of PERK-eIF2Ξ± axis controlling transcriptional programs of translation, secretion, and cell death during ER stress responses
PMID: 33384352
2
QRICH1 regulates ATF6 transcription to modulate pathological cardiac hypertrophy
PMID: 40355839
3
QRICH1 is core component of zincore complex that stabilizes zinc finger transcription factors onto DNA
PMID: 40608935
4
QRICH1 negatively regulates CARD11 signaling to fine-tune CD8+ T cell activation
PMID: 40085689
5
QRICH1 is involved in chondrocyte hypertrophy required for normal longitudinal bone growth
PMID: 30281152
6
Heterozygous QRICH1 variants cause neurodevelopmental disorder with developmental delay, intellectual disability, dysmorphism, hypotonia, seizures, and brain anomalies
PMID: 34859529
7
De novo QRICH1 missense variants are associated with polymicrogyria
PMID: 37486637
Disease Associationsβ“˜21
Ververi-Brady syndrome 1Open Targets
0.76Strong
Intellectual disabilityOpen Targets
0.55Moderate
genetic disorderOpen Targets
0.53Moderate
Down syndromeOpen Targets
0.37Weak
syndromic complex neurodevelopmental disorderOpen Targets
0.37Weak
Mild intellectual disabilityOpen Targets
0.34Weak
neurodegenerative diseaseOpen Targets
0.32Weak
autism spectrum disorderOpen Targets
0.12Weak
Abnormality of the skeletal systemOpen Targets
0.12Weak
hypertensionOpen Targets
0.10Suggestive
hepatocellular carcinomaOpen Targets
0.07Suggestive
acute lymphoblastic leukemiaOpen Targets
0.07Suggestive
cardiac hypertrophyOpen Targets
0.07Suggestive
smoking cessationOpen Targets
0.07Suggestive
HeterotaxiaOpen Targets
0.06Suggestive
health study participationOpen Targets
0.06Suggestive
congenital unilateral hypoplasia of depressor anguli orisOpen Targets
0.05Suggestive
genito-palato-cardiac syndromeOpen Targets
0.05Suggestive
metabolic syndromeOpen Targets
0.05Suggestive
Congenitally uncorrected transposition of the great arteriesOpen Targets
0.05Suggestive
Ververi-Brady syndrome 1UniProt
Pathogenic Variants73
NM_198880.3(QRICH1):c.1531C>T (p.Arg511Ter)Pathogenic
Ververi-Brady syndrome|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 511
NM_198880.3(QRICH1):c.1149_1150del (p.Phe384fs)Pathogenic
not provided|Ververi-Brady syndrome|Inborn genetic diseases|Ververi-Brady syndrome 1
β˜…β˜…β˜†β˜†2025β†’ Residue 384
NM_198880.3(QRICH1):c.1649A>G (p.Tyr550Cys)Likely pathogenic
Ververi-Brady syndrome|not provided|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 550
NM_198880.3(QRICH1):c.1606C>T (p.Arg536Ter)Pathogenic
Ververi-Brady syndrome|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 536
NM_198880.3(QRICH1):c.1655del (p.Phe552fs)Likely pathogenic
Ververi-Brady syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 552
NM_198880.3(QRICH1):c.46C>T (p.Arg16Ter)Pathogenic
Ververi-Brady syndrome|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 16
NM_198880.3(QRICH1):c.961del (p.Asp321fs)Pathogenic
Ververi-Brady syndrome|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 321
NM_198880.3(QRICH1):c.1787-2A>GPathogenic
Ververi-Brady syndrome|not provided
β˜…β˜…β˜†β˜†2023
NM_198880.3(QRICH1):c.136del (p.Gln46fs)Pathogenic
Ververi-Brady syndrome|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 46
NM_198880.3(QRICH1):c.1378C>T (p.Gln460Ter)Pathogenic
Ververi-Brady syndrome
β˜…β˜…β˜†β˜†2021β†’ Residue 460
NM_198880.3(QRICH1):c.914dup (p.Gly306fs)Likely pathogenic
Intellectual disability|Ververi-Brady syndrome
β˜…β˜…β˜†β˜†2021β†’ Residue 306
NM_198880.3(QRICH1):c.1292dup (p.Pro432fs)Pathogenic
Ververi-Brady syndrome|Inborn genetic diseases
β˜…β˜…β˜†β˜†2021β†’ Residue 432
NM_198880.3(QRICH1):c.832_833del (p.Ser278fs)Pathogenic
Intellectual disability|Ververi-Brady syndrome
β˜…β˜…β˜†β˜†2021β†’ Residue 278
NM_198880.3(QRICH1):c.1147_1150del (p.Leu383fs)Pathogenic
Ververi-Brady syndrome
β˜…β˜…β˜†β˜†2021β†’ Residue 383
NM_198880.3(QRICH1):c.1954C>T (p.Arg652Ter)Pathogenic
Ververi-Brady syndrome|Intellectual disability|not provided
β˜…β˜…β˜†β˜†2021β†’ Residue 652
NM_198880.3(QRICH1):c.1812_1813del (p.Glu605fs)Pathogenic
Mild intellectual disability|Ververi-Brady syndrome
β˜…β˜…β˜†β˜†2021β†’ Residue 605
NM_198880.3(QRICH1):c.2012T>A (p.Leu671Ter)Pathogenic
Ververi-Brady syndrome
β˜…β˜†β˜†β˜†2026β†’ Residue 671
NM_198880.3(QRICH1):c.1671+1G>APathogenic
Ververi-Brady syndrome 1
β˜…β˜†β˜†β˜†2026
NM_198880.3(QRICH1):c.1324C>T (p.Gln442Ter)Pathogenic
Ververi-Brady syndrome 1
β˜…β˜†β˜†β˜†2025β†’ Residue 442
NM_198880.3(QRICH1):c.214dup (p.Ser72fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 72
View on ClinVar β†—
Related Genes
GMPSProtein interaction92%EPHX2Protein interaction86%QRICH2Protein interaction74%ATF6BShared pathway29%CREB3Shared pathway25%ATF6Shared pathway25%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
49%
Ovary
44%
Heart
39%
Liver
35%
Brain
26%
Gene Interaction Network
Click a node to explore
QRICH1GMPSEPHX2QRICH2ATF6BCREB3ATF6
PROTEIN STRUCTURE
Preparing viewer…
PDB9HJU Β· 3.16 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.26Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.17 [0.11–0.26]
RankingsWhere QRICH1 stands among ~20K protein-coding genes
  • #7,600of 20,598
    Most Researched61
  • #1,013of 5,498
    Most Pathogenic Variants73 Β· top quartile
  • #850of 17,882
    Most Constrained (LOEUF)0.26 Β· top 5%
Genes detectedQRICH1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder.
PMID: 34859529
Hum Mutat Β· 2022
1.00
2
QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis.
PMID: 33384352
Science Β· 2021
0.90
3
Exome Sequencing and the Identification of New Genes and Shared Mechanisms in Polymicrogyria.
PMID: 37486637
JAMA Neurol Β· 2023
0.80
4
QRICH1 mediates an intracellular checkpoint for CD8
PMID: 40085689
Sci Immunol Β· 2025
0.70
5
De novo variants underlying monogenic syndromes with intellectual disability in a neurodevelopmental cohort from India.
PMID: 38114583
Eur J Hum Genet Β· 2024
0.60